> ## Content Index > Fetch the complete content index at: https://www.moatmarginresearch.com/llms.txt > Use this file to discover other available public pages before exploring further. # Rainbow Childrens Medicare Moat Analysis: Score & Risks - URL: https://www.moatmarginresearch.com/rainbow-childrens-medicare-moat/ - Published: 2026-08-16T17:02:25.000Z - Updated: 2026-08-22T05:13:21.000Z - Author: A K Karthikeyan - Tags: First-pass note, Coverage Moat Note · First-pass ## Rainbow Childrens Medicare Ltd. A first-pass moat teardown of Rainbow Childrens Medicare Ltd., built from single-pass filing evidence. Free note — provisional, and the full two-pass deep dive may revise it. **Moat & Margin**16 Aug 2026 First-pass · \~3 min 4.70 / 10 NARROWProcess/Data-led First-pass narrow read — primary edge in Efficient Scale. Provisional, single-pass evidence. Provisional score · subject to modification based on new evidence Rainbow Childrens Medicare Ltd. scores **4.7** on MoatSCORE 6.0 — a narrow moat in Pharma. This is a **first-pass note**: the dimensional read and the filing receipts below come from a single GFIP evidence pass, not the full two-pass deep corpus behind our flagship deep dives. Provisional — published free while the deep version is queued. The teardown ## Seven dimensions of moat Ordered by contribution. Each dimension carries a verified filing quote, graded **\[M\]** mechanism or **\[O\]** outcome. D6Efficient Scale5.5 M · Mechanism✓ Verified verbatim “Notably, we are the only Paediatric hospital chain in the country with three JCI Accredited hospitals facilities.” **Rainbow Childrens Medicare Ltd.** · Earnings Call · p.4 D1Network Effects4.8 M · Mechanism✓ Verified verbatim “we continue to remain the only pediatric hospital chain in India with three hospitals accredited by the Joint Commission International (JCI) and 13 NABH-accredited hospitals across the network” **Rainbow Childrens Medicare Ltd.** · FY2024-25 Annual Report · p.10 D3Cost Advantage4.8 O · Outcome✓ Verified verbatim “As at 31 March 2025, leasehold improvements and medical equipments include Rs.92.60 million and Rs 26.91 million (31 March 2024: Rs.98.74 million and Rs 36.83 million) respectively in respect of this hospital.” **Rainbow Childrens Medicare Ltd.** · Xbrl Text 1 quote extracted here — not one mechanism-class. The evidence is outcome-only. D4Price Discretion4.7 M · Mechanism✓ Verified verbatim “We saw about a 0.9% margin impact compared to the previous year.” **Rainbow Childrens Medicare Ltd.** · Earnings Call · p.7 D5Intangible Assets4.7 M · Mechanism✓ Verified verbatim “the PAT was down by 4.2% to INR39.7 crores due to higher depreciation and finance costs.” **Rainbow Childrens Medicare Ltd.** · Earnings Call · p.3 D2Switching Costs4.5 No verified filing quote surfaced for this dimension in the first-pass evidence sweep. D7Counter-PositioningExcluded— Excluded for this archetype. D8Ungoverned RiskUnscored · Layer 2.5 D8 rating: **ADEQUATE**. Not part of the moat score — it governs the cost of equity and the fade window. First-pass; not yet deep-reviewed. The barrier gate ## The barrier gate — first-pass Replication — can a rival copy it?5.0 How hard it is for a rival to copy the edge (first-pass estimate). Bypass — can a rival route around it?5.0 How easily a rival can route around the edge (first-pass estimate). Effective barrier 5 — below 6, so the band is capped narrow. First-pass estimate. What would change our mind 1. **Deep two-pass review.** This draft rests on a single GFIP evidence pass; the full 10-year AR + concall corpus may move the read. 2. **The barrier gate.** A firmer replication or bypass estimate is the most likely thing to shift the band. 3. **Adverse events.** Any governance, regulatory or funding shock captured in D8 could re-rate the fade window. First-pass note — provisional single-pass MoatSCORE 6.0 read, not the full deep dive. Educational research, not investment advice; no buy/sell recommendation, no price target. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser. **Where this note fits.** This company is one of **509 Indian companies** we have scored for moat durability — 370 narrow, 126 narrow-trending-wide, none wide. Every score, dimension by dimension, is free in the [Moat Screener](https://www.moatmarginresearch.com/moat-screener/).